Jarrod Longcor - Jun 23, 2023 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role: Chief Operating Officer
Signature: /s/ Christina Blakley, Attorney in-fact for Jarrod D. Longcor
Stock symbol: CLRB
Transactions as of: Jun 23, 2023
Transactions value $: $0
Form type: 4
Date filed: 12/12/2023, 08:04 PM
Previous filing: Jan 18, 2023
Next filing: Jun 18, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLRB	Common Stock	Award	$0	+42.9K	+420.28%	$0.00	53.1K	Dec 8, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLRB	Stock option (right to buy)	Award	$0	+144K		$0.00	144K	Jun 23, 2023	Common Stock	144K	$1.68	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was contingently granted on January 16, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2023 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 23, 2023. Because January 16, 2023 was a federal holiday, the option was priced on the following trading day.
F2	This option shall vest over a period of three years from January 17, 2023, with 1/3 vesting on the first anniversary of January 17, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of January 17, 2023.